Roivant to Stop Lung Disease Drug Development After Trial Failure ...Middle East

Roivant will discontinue the development of its drug for a rare lung disease after it failed to show treatment benefits in patients in a mid-stage trial. Reuters Health Information

Read More Details
Finally We wish PressBee provided you with enough information of ( Roivant to Stop Lung Disease Drug Development After Trial Failure )

Also on site :

• Inside the Target CEO meeting with Black leaders amid the company’s DEI rollback and the boycott that followed
• The Simple Spaghetti Recipe Isabella Rossellini Swears By
• 7 Signs It’s Time to Take Your Memory Issues Seriously